These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2494933)

  • 21. Resistance of normal or immunized guinea pigs against a subcutaneous challenge of Brucella abortus.
    Pardon P; Marly J
    Ann Rech Vet; 1978; 9(3):419-25. PubMed ID: 107845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus.
    Cheville NF; Stevens MG; Jensen AE; Tatum FM; Halling SM
    Am J Vet Res; 1993 Oct; 54(10):1591-7. PubMed ID: 8250382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: immunity.
    Alton GG; Jones LM; García-Carrillo C; Trenchi A
    Am J Vet Res; 1972 Sep; 33(9):1747-51. PubMed ID: 4626469
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis.
    Cheville NF; Olsen SC; Jensen AE; Stevens MG; Palmer MV; Florance AM
    Am J Vet Res; 1996 Aug; 57(8):1153-6. PubMed ID: 8836366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune serum-mediated effects on brucellosis evolution in mice.
    Plommet M; Plommet AM
    Infect Immun; 1983 Jul; 41(1):97-105. PubMed ID: 6408007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens.
    Ramamoorthy S; Sanakkayala N; Vemulapalli R; Duncan RB; Lindsay DS; Schurig GS; Boyle SM; Kasimanickam R; Sriranganathan N
    Int J Parasitol; 2007 Nov; 37(13):1521-9. PubMed ID: 17568587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
    Dénes B
    Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abortion and placentitis in pregnant bison (Bison bison) induced by the vaccine candidate, Brucella abortus strain RB51.
    Palmer MV; Olsen SC; Gilsdorf MJ; Philo LM; Clarke PR; Cheville NF
    Am J Vet Res; 1996 Nov; 57(11):1604-7. PubMed ID: 8915438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.
    Olsen SC
    Vet Ther; 2000; 1(3):183-91. PubMed ID: 19757581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in organs after vaccination with Br. abortus B-8 strain].
    Iazykova KN; Erzh NI
    Veterinariia; 1973 Apr; (4):41-2. PubMed ID: 4218919
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of oxytetracycline administration on antibody response to Brucella abortus vaccination in calves.
    Smith RA; Thedford TR; Espe BH; Woodson PD; Burrows GE
    J Am Vet Med Assoc; 1983 Jul; 183(1):70-1. PubMed ID: 6409863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51.
    Elzer PH; Enright FM; Colby L; Hagius SD; Walker JV; Fatemi MB; Kopec JD; Beal VC; Schurig GG
    Am J Vet Res; 1998 Dec; 59(12):1575-8. PubMed ID: 9858409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of antibrucellosis vaccines using guinea pigs].
    Le Garrec Y; Pilet C; Garrido-Calderon N
    Dev Biol Stand; 1976; 31():301-7. PubMed ID: 816686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of exogenous recombinant interleukin-12 on immune responses and protection against Brucella abortus in a murine model.
    Lee IK; Olsen SC; Bolin CA
    Can J Vet Res; 2001 Oct; 65(4):223-8. PubMed ID: 11768128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence.
    Lord VR; Schurig GG; Cherwonogrodzky JW; Marcano MJ; Melendez GE
    Am J Vet Res; 1998 Aug; 59(8):1016-20. PubMed ID: 9706206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of antibrucellic vaccines in mice].
    Valette L; Stellmann C
    Dev Biol Stand; 1976; 31():308-13. PubMed ID: 816687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control methods and thresholds of acceptability for antibrucella vaccines.
    Bosseray N
    Dev Biol Stand; 1992; 79():121-8. PubMed ID: 1286747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle.
    Palmer MV; Olsen SC; Cheville NF
    Am J Vet Res; 1997 May; 58(5):472-7. PubMed ID: 9140553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.